These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16618579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    van Laarhoven HW, Kaanders JH, Lok J, Peeters WJ, Rijken PF, Wiering B, Ruers TJ, Punt CJ, Heerschap A, van der Kogel AJ.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):473-82. PubMed ID: 16242253
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas.
    Wijffels KI, Marres HA, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Oral Oncol; 2008 Apr 01; 44(4):335-44. PubMed ID: 17689286
    [Abstract] [Full Text] [Related]

  • 5. Deregulation of EGFR/VEGF/HIF-1a signaling pathway in colon adenocarcinoma based on tissue microarrays analysis.
    Rigopoulos DN, Tsiambas E, Lazaris AC, Kavantzas N, Papazachariou I, Kravvaritis C, Tsounis D, Koliopoulou A, Athanasiou AE, Karameris A, Manaios L, Sergentanis TN, Patsouris E.
    J BUON; 2010 Apr 01; 15(1):107-15. PubMed ID: 20414936
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia.
    Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH.
    Eur J Cancer; 2009 Nov 01; 45(16):2906-14. PubMed ID: 19699082
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis.
    Atkin G, Taylor NJ, Daley FM, Stirling JJ, Richman P, Glynne-Jones R, d'Arcy JA, Collins DJ, Padhani AR.
    Br J Surg; 2006 Aug 01; 93(8):992-1000. PubMed ID: 16673354
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas.
    Hoogsteen IJ, Peeters WJ, Marres HA, Rijken PF, van den Hoogen FJ, van der Kogel AJ, Kaanders JH.
    Radiother Oncol; 2005 Aug 01; 76(2):213-8. PubMed ID: 16112214
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. No detectable hypoxia in malignant salivary gland tumors: preliminary results.
    Wijffels KI, Hoogsteen IJ, Lok J, Rijken PF, Marres HA, de Wilde PC, van der Kogel AJ, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1319-25. PubMed ID: 18973979
    [Abstract] [Full Text] [Related]

  • 14. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, Tumour Angiogenesis Research Group.
    J Clin Oncol; 2006 Sep 10; 24(26):4301-8. PubMed ID: 16896001
    [Abstract] [Full Text] [Related]

  • 15. Chromogranin A-, serotonin-, synaptophysin- and vascular endothelial growth factor-positive endocrine cells and the prognosis of colorectal cancer: an immunohistochemical and ultrastructural study.
    Gulubova M, Vlaykova T.
    J Gastroenterol Hepatol; 2008 Oct 10; 23(10):1574-85. PubMed ID: 18771509
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: implications for radioresistance.
    Carnell DM, Smith RE, Daley FM, Saunders MI, Bentzen SM, Hoskin PJ.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):91-9. PubMed ID: 16563659
    [Abstract] [Full Text] [Related]

  • 18. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A, Landuyt W, Pastorekova S, Moons J, Goethals L, Haustermans K, Nafteux P, Penninckx F, Geboes K, Lerut T, Ectors N.
    Ann Surg; 2006 Mar 01; 243(3):334-40. PubMed ID: 16495697
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
    Ozbudak IH, Ozbilim G, Kucukosmanoglu I, Dertsiz L, Demircan A.
    Int J Surg Pathol; 2009 Oct 01; 17(5):390-5. PubMed ID: 18849317
    [Abstract] [Full Text] [Related]

  • 20. Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease.
    Khalifa MA, Rowsell CH, Gladdy RA, Ko YJ, Hanna S, Smith A, Law C.
    Am J Clin Pathol; 2006 Feb 01; 125(2):229-33. PubMed ID: 16393679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.